Aptevo Therapeutics Inc (NASDAQ:APVO) traded at $1.17 at last check on current trade day and made an upward move of 35.24% on its previous day’s price.
Looking at the stock we see that its previous close was $0.86 and the beta (5Y monthly) reads 5.747 with the day’s price range being $1.05 – $1.32. In terms of its 52-week price range, APVO has a high of $51.06 and a low of $0.83. The company’s stock has lost about -52.81% over that past 30 days.
Aptevo Therapeutics Inc has a market cap of $3.76 million and is expected to release its quarterly earnings report on 2025-Feb-13.
On the other hand, looking at the outlook for the APVO stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Looking further, we note the current price level is -8.04% off its SMA20 and -50.54% from its 50-day simple moving average. The RSI (14) is pointing at 40.27 while the volatility over the past week is 10.53% and jumps to 34.25% over the past one month. The beta value is 5.89, while the average true range (ATR) is currently pointing at 0.36.
Coming back to Aptevo Therapeutics Inc (NASDAQ:APVO), we note that the average 3-month trading volume was 1.88 million, while that of the preceding 10-day period stands at 0.92 million. Current shares outstanding are 3.22 million.
The insiders hold 0.01% of the company’s shares while institutions hold 7.71%. The data shows that short shares as of 2025-03-31, stood at 0.39 million at a short ratio of 4.92. This represents a 2650.00 short interest in shares outstanding on 2025-03-31. Shares short rose in March from the previous month at 60058.0. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -72.96% down in year-to-date price movement.
